Author: gammy

WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)

RAHWAY, NJ and TOKYO, Mar 2, 2026 – (JCN Newswire via SeaPRwire.com) – Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada) and Eisai (Headquarters: Tokyo, CEO: Haruo Naito) today announced the

More

The University of Tokyo, NTT, and NEC demonstrate real-time augmented reality assistance made possible by integrating three newly proposed technologies on a 6G/IOWN platform to realize the widespread use of AI agents supporting safety and security

Highlights: Integration of the proposed technologies will help address the transmission and computational infrastructure challenges faced when implementing AI agents. This trial verified the effectiveness of optimizing the transmission and computational processing of high-volume data handled by AI agents. This

More